Related Experiment Video
Updated: Apr 12, 2026

Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
Published on: October 20, 2023
Open Source Bayesian Models. 1. Application to ADME/Tox and Drug Discovery Datasets.
Alex M Clark1, Krishna Dole2, Anna Coulon-Spektor2
1†Molecular Materials Informatics, Inc., 1900 St. Jacques No. 302, Montreal H3J 2S1, Quebec, Canada.
This study introduces an open-source Bayesian modeling tool for drug discovery, enhancing accessibility of absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) models. The software enables rapid development of robust predictive models from diverse datasets.
Area of Science:
- Computational chemistry
- cheminformatics
- Drug discovery modeling
Background:
- Hundreds of absorption, distribution, metabolism, excretion, and toxicity (ADME/Tox) and bioactivity models exist but lack public accessibility, hindering drug discovery.
- Sharing computational models remains a significant challenge in the field.
Purpose of the Study:
- To develop and release an open-source Bayesian model-building software module to improve accessibility and collaboration in drug discovery.
- To demonstrate the module's capability in generating robust predictive models for various properties.
Main Methods:
- Created a reference implementation of a Bayesian model-building module released as open-source software.
- Integrated the module into the Chemistry Development Kit (CDK), CDD Vault, and mobile applications.
- Built Bayesian models for ADME/Tox, bioactivity, and physicochemical properties using FCFP6 descriptors.
Main Results:
- The developed Bayesian models achieved cross-validation receiver operator curve values comparable to previously published models.
- The implementation enables rapid production of robust machine learning models using public or private datasets.
- Demonstrated successful model generation in proprietary software (CDD Vault) and export for open-source use (CDK).
Conclusions:
- The open-source Bayesian modeling tool enhances the accessibility and portability of predictive models in drug discovery.
- This approach facilitates biocomputation across distributed datasets, accelerating the identification of potential drug candidates.
- The integration of proprietary and open-source software promotes collaborative research and development.
More Related Videos
14:34A Bilingual Computational Workflow for Identifying Potential PLK1 Inhibitors in American Sign Language and English
Published on: April 3, 2026
05:47In Silico Modeling Method for Computational Aquatic Toxicology of Endocrine Disruptors: A Software-Based Approach Using QSAR Toolbox
Published on: August 28, 2019
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This...
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Model Approaches for Pharmacokinetic Data: Physiological Models